Latest News and Press Releases

NEW YORK, March 20, 2026 (GLOBE NEWSWIRE) -- TMC the metals company Inc. (Nasdaq: TMC) (“TMC” or the “Company”), a leading developer of the world’s largest estimated undeveloped resource of critical...

Melbourne, Australia, March 20, 2026 (GLOBE NEWSWIRE) -- Nova Minerals Limited (“Nova” or the “Company”) (NASDAQ: NVA) (ASX: NVA) (FRA: QM3) is pleased to provide an opportunity for its...

New York City, NY, March 20, 2026 (GLOBE NEWSWIRE) -- The American online entertainment market has reached an inflection point. No deposit access to real money slots is no longer a marketing...

Groupama publie des résultats très satisfaisants, avec une hausse du résultat opérationnel économique de + 22,8% et un résultat net d’1,0 milliard d’euros. Chiffre d’affaires (primes d’assurance et...

Groupama delivered very strong results, with economic operating income up 22.8% and net income reaching €1.0 billion. Premium income (insurance premiums and other income) of €20.0 billion, up +8.4% ...

-- First and only FDA-approved therapy for the treatment of acquired hypothalamic obesity, a rare disease characterized by accelerated and sustained weight gain caused by hypothalamic injury or...

BETHESDA, Md., March 19, 2026 (GLOBE NEWSWIRE) -- Gain Therapeutics, Inc. (Nasdaq: GANX) (“Gain”, or the “Company”), a clinical-stage biotechnology company leading the discovery and development of...

Paris, le 19 mars 2026 MISE À DISPOSITION DU DOCUMENT D’ENREGISTREMENT UNIVERSEL 2025INCLUANT LE RAPPORT FINANCIER ANNUEL Le Document d’enregistrement universel d’Hermès International relatif à...

Paris, 19 March 2026 AVAILABILITY OF THE 2025 UNIVERSAL REGISTRATION DOCUMENTINCLUDING THE ANNUAL FINANCIAL REPORT Hermès International filed its 2025 Universal Registration Document with the...

Company AnnouncementCOPENHAGEN, Denmark; March 19, 2026 – Genmab A/S (Nasdaq: GMAB) Following Genmab A/S’ Annual General Meeting held on March 19, 2026, the Company’s Board of Directors met to...